Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Volume 44, Issue 6, Pages 688-695Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00005344-200412000-00011
Keywords
eugenol; myocardial contractility; calcium; isoproterenol; tetanic tension; calcium channels; myosin ATPase
Funding
- NHLBI NIH HHS [HL58861, HL071015] Funding Source: Medline
Ask authors/readers for more resources
Eugenol (EUG) acts as a calcium antagonist but effects on the contractile proteins could also occur. We investigated inotropic effects of EUG in rat left ventricular papillary muscles, measuring isometric force, time variables, and post rest potentiation and EUG actions on the effects of Ca2+ (0.62 to 2.5 mM) and isoproterenol (5 ng/ml), on myosin ATPase activity and on the calcium currents in single ventricular myocytes. EUG reduced tension and time variables without altering the sarcoplasmic reticulum activity increasing post-pause relative potentiation. Isoproterenol and Ca2+ counteract these negative inotropic effects. Tetanic tension diminished, but not the myosin ATPase activity suggesting an isolated sarcolemmal effect. EUG 0.1 mM decreased the Ca2+ current amplitude in the entire potential range tested and 0.5 mM almost completely blocked this inward current. Results suggested that EUG depresses force without affecting the contractile machinery and its action is the only dependent blockade of the calcium inward current.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available